Issued Patents All Time
Showing 1–25 of 61 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12377175 | Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies | James Michael Kelly, Alejandro Amor-Coarasa, Shashikanth Ponnala | 2025-08-05 |
| 12307798 | System and method for automated processing of electronic records with machine learning models | — | 2025-05-20 |
| 12297157 | 18F-labeled peptide ligands useful in PET and Cerenkov luminescene imaging | — | 2025-05-13 |
| 12268759 | Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies | James Michael Kelly, Alejandro Amor-Coarasa, Shashikanth Ponnala | 2025-04-08 |
| 12258339 | Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer | Justin Wilson, Nikki Thiele, James Michael Kelly, Shashikanth Ponnala | 2025-03-25 |
| 12186288 | Double targeted constructs to affect tumor kill | James Michael Kelly, Alejandro Amor-Coarasa, Shashikanth Ponnala | 2025-01-07 |
| 12103922 | Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer | Justin Wilson, Nikki Thiele, James Michael Kelly, Shashikanth Ponnala | 2024-10-01 |
| 11712485 | Triazine based radiopharmaceuticals and radioimaging agents | Craig Zimmerman, John Joyal, Genliang Lu | 2023-08-01 |
| 11285227 | Trifunctional constructs with tunablepharmacokinetics useful in imaging and anti-tumor therapies | James Michael Kelly, Alejandro Amor-Coarasa, Shashikanth Ponnala | 2022-03-29 |
| 11279698 | Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer | Justin Wilson, Nikki Thiele, James Michael Kelly, Shashikanth Ponnala | 2022-03-22 |
| 11167049 | Organ protection in PSMA-targeted radionuclide therapy of prostate cancer | Shawn Hillier, John Joyal | 2021-11-09 |
| 10898598 | Triazine based radiopharmaceuticals and radioimaging agents | Craig Zimmerman, John Joyal, Genliang Lu | 2021-01-26 |
| 10806806 | Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies | Alejandro Amor-Coarasa, James Michael Kelly, Shashikanth Ponnala | 2020-10-20 |
| 10716772 | Double targeted constructs to affect tumor kill | James Michael Kelly, Alejandro Amor-Coarasa, Shashikanth Ponnala | 2020-07-21 |
| 10668174 | Organ protection in PSMA-targeted radionuclide therapy of prostate cancer | Shawn Hillier, John Joyal | 2020-06-02 |
| 10647666 | Heterodimers of glutamic acid | Craig Zimmerman, Kevin P. Maresca | 2020-05-12 |
| 10640461 | Heterodimers of glutamic acid | Craig Zimmerman, Kevin P. Maresca | 2020-05-05 |
| 10201624 | Triazine based radiopharmaceuticals and radioimaging agents | Craig Zimmerman, John Joyal, Genliang Lu | 2019-02-12 |
| 10179117 | Double targeted constructs to affect tumor kill | James Michael Kelly, Alejandro Amor-Coarasa, Shashikanth Ponnala | 2019-01-15 |
| 10131627 | Heterodimers of glutamic acid | Craig Zimmerman, Kevin P. Maresca | 2018-11-20 |
| 10086096 | Triazine based radiopharmaceuticals and radioimaging agents | Craig Zimmerman, John Joyal, Genliang Lu | 2018-10-02 |
| 9956305 | Organ protection in PSMA-targeted radionuclide therapy of prostate cancer | Shawn Hillier, John Joyal | 2018-05-01 |
| 9878980 | Heterodimers of glutamic acid | Craig Zimmerman, Kevin P. Maresca | 2018-01-30 |
| 9687572 | PSMA-targeted dendrimers | John Joyal, Craig Zimmerman | 2017-06-27 |
| 9447121 | Triazine based radiopharmaceuticals and radioimaging agents | Craig Zimmerman, John Joyal, Genliang Lu | 2016-09-20 |